| 000 | 01819 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250516070245.0 | ||
| 264 | 0 | _c20120803 | |
| 008 | 201208s 0 0 eng d | ||
| 022 | _a1464-3405 | ||
| 024 | 7 |
_a10.1016/j.bmcl.2011.11.071 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStokes, Suzanne S | |
| 245 | 0 | 0 |
_aDiscovery of bacterial NAD⁺-dependent DNA ligase inhibitors: improvements in clearance of adenosine series. _h[electronic resource] |
| 260 |
_bBioorganic & medicinal chemistry letters _cJan 2012 |
||
| 300 |
_a85-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdenine _xchemistry |
| 650 | 0 | 4 |
_aAdenosine _xchemistry |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xchemical synthesis |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 |
_aChromatography, Liquid _xmethods |
| 650 | 0 | 4 |
_aDNA Ligases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 |
_aDrug Evaluation, Preclinical _xmethods |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aFluorine _xchemistry |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 |
_aMass Spectrometry _xmethods |
| 650 | 0 | 4 | _aModels, Chemical |
| 650 | 0 | 4 |
_aNAD _xchemistry |
| 650 | 0 | 4 | _aRats |
| 700 | 1 | _aGowravaram, Madhusudhan | |
| 700 | 1 | _aHuynh, Hoan | |
| 700 | 1 | _aLu, Min | |
| 700 | 1 | _aMullen, George B | |
| 700 | 1 | _aChen, Brendan | |
| 700 | 1 | _aAlbert, Robert | |
| 700 | 1 | _aO'Shea, Thomas J | |
| 700 | 1 | _aRooney, Michael T | |
| 700 | 1 | _aHu, Haiqing | |
| 700 | 1 | _aNewman, Joseph V | |
| 700 | 1 | _aMills, Scott D | |
| 773 | 0 |
_tBioorganic & medicinal chemistry letters _gvol. 22 _gno. 1 _gp. 85-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmcl.2011.11.071 _zAvailable from publisher's website |
| 999 |
_c21377585 _d21377585 |
||